In a report released on February 23, Rishi Jaluria from RBC Capital maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a ...
RBC Capital analyst Brian Abrahams maintained a Buy rating on BioCryst (BCRX – Research Report) yesterday and set a price target of $11.00. The ...
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 28% bearish. Among these notable ...
In a move that stunned the City, Unilever said Hein Schumacher will be replaced at the end of the week by finance chief ...
The outlook for FY25 remains positive, with consensus forecasting a 10% revenue increase. In the Asia-Pacific region, sales declined by 1% and missed consensus expectations by 2%, but EBITDA margins ...
The FTSE 100 closed in positive territory on Tuesday, although well off early highs, as a marked drop in US consumer confidence knocked Wall Street. The FTSE 100 index closed up 9.69 points, 0.1%, at ...
Muni prices continue to "show relative resilience" despite a nearly record pace of issuance, said Matt Fabian, a partner at ...
Analysts described Schumacher's successor Fernando Fernandez - an appointment from inside Unilever - as 'fiery and ...
Chemours (NYSE:CC – Get Free Report) had its price objective lowered by research analysts at Barclays from $23.00 to $19.00 in a research note issued on Monday,Benzinga reports. The brokerage ...
Toronto-Dominion Bank (NYSE:TD – Get Free Report) (TSE:TD) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. TD has ...
Unilever's board, which includes billionaire activist investor Nelson Peltz, was unified in its decision to oust CEO ...
Would you like to be notified of the latest news and updates on the stock market?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results